CRINETICS PHARMACEUTICALS INC. 2023-2024 Proxy Voting Records

Description as filed by funds: To elect two directors to serve as Class III directors for a three-year term to expire at the 2027 annual meeting of stockholders: Camille Bedrosian, M.D.

CRINETICS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Camille Bedrosian, M.D.”): 50,829,173 for, 14,947,321 withheld, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 86 asset managers below reported 24,727,122 for, 128 against, 4,324,565 withheld.

Showing the 25 largest of 86 asset managers. See all 86 in the interactive database.

Description as filed by funds: To elect two directors to serve as Class III directors for a three-year term to expire at the 2027 annual meeting of stockholders: Wendell Wierenga, Ph.D.

CRINETICS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Wendell Wierenga, Ph.D.”): 50,300,772 for, 15,475,722 withheld, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 86 asset managers below reported 24,462,565 for, 128 against, 4,589,122 withheld.

Showing the 25 largest of 86 asset managers. See all 86 in the interactive database.

Description as filed by funds: To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and

CRINETICS PHARMACEUTICALS INC.’s own tally for this item (“3. Approval, on an advisory basis, of the compensation of the Company's named executive officers”): 64,052,127 for, 1,745,589 against — passed, per its Form 8-K filed June 10, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Three - Approval, on an advisory basis, of the compensation of the Company's named executive officers The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 85 managers: 28,800,903 for, 250,784 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 187 managers: 51,701,946 for, 1,492,954 against, 1,260 abstained, 800 not voted, 11 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To consider and vote upon the ratification of the selection of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2024;

CRINETICS PHARMACEUTICALS INC.’s own tally for this item (“2. Ratification of Selection of Independent Registered Accounting Firm”): 67,973,983 for, 115,422 against — passed, per its Form 8-K filed June 10, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Two - Ratification of Selection of Independent Registered Accounting Firm The Company's stockholders ratified the selection of BDO USA, P.C. as the Company's independent registered accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 86 asset managers below reported 29,048,580 for, 3,235 against.

Showing the 25 largest of 86 asset managers. See all 86 in the interactive database.